Gravitics Holdings, which develops space structures and orbital systems, lowered the proposed deal size for its upcoming IPO on Tuesday. The Miami, FL-based company now plans to raise $50 million by offering 3.2 million shares at a price range of $14 to $17....read more
Gravitics Holdings, which develops space structures and orbital systems, announced terms for its IPO on Thursday. The Miami, FL-based company plans to raise $125 million by offering 8.1 million shares at a price range of $14 to $17. At the midpoint of the...read more
One IPO priced this past week, joined by four SPACs. Cardiovascular disease biotech Scribe Therapeutics (SCTX) upsized and priced at the high end to raise $129 million at a $273 million market cap. Scribe is developing in vivo CRISPR-based therapies, with an ...read more
Gravitics Holdings, which develops large space structures and orbital systems, filed on Monday with the SEC to raise up to $125 million in an initial public offering. Gravitics Holdings is engaged in the design, development, and commercialization of large...read more
Space systems developer Gravitics Holdings slashes share offering by 60% ahead of $50 million IPO
Gravitics Holdings, which develops space structures and orbital systems, lowered the proposed deal size for its upcoming IPO on Tuesday. The Miami, FL-based company now plans to raise $50 million by offering 3.2 million shares at a price range of $14 to $17....read more
Space systems developer Gravitics Holdings sets terms for $125 million Nasdaq IPO
Gravitics Holdings, which develops space structures and orbital systems, announced terms for its IPO on Thursday. The Miami, FL-based company plans to raise $125 million by offering 8.1 million shares at a price range of $14 to $17. At the midpoint of the...read more
US IPO Weekly Recap: CRISPR biotech pops 44% as more names join the IPO pipeline
One IPO priced this past week, joined by four SPACs. Cardiovascular disease biotech Scribe Therapeutics (SCTX) upsized and priced at the high end to raise $129 million at a $273 million market cap. Scribe is developing in vivo CRISPR-based therapies, with an ...read more
Orbital systems developer Gravitics Holdings files for a $125 million Nasdaq listing
Gravitics Holdings, which develops large space structures and orbital systems, filed on Monday with the SEC to raise up to $125 million in an initial public offering. Gravitics Holdings is engaged in the design, development, and commercialization of large...read more